List of companies in Boehringer Ingelheim Venture Fund's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases. | ||||||
Developer of immunotherapy for the treatment of infectious diseases. | ||||||
Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions | ||||||
AI-powered pathology solutions provider for drug development and diagnostics. | ||||||
A biotechnology company developing immuno-oncology therapies and therapeutic vaccines | ||||||
Immuno-modulatory antibodies | ||||||
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease. | ||||||
Rigontec GmbH is a biotechnology company and developer of technology for accessing the retinoic acid-inducible gene pathway. | ||||||
Optina Diagnostics develops technology for the early detection of disease through the eye. | ||||||
Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005. | ||||||
Agonistic monoclonal antibody molecules | ||||||
Asgard Therapeutics is a cancer Immunotherapy founded in 2018. | ||||||
Oncolytic Immunotherapy | ||||||
ArmaGen Technologies is a Calabasas, California-based company founded by William M. Pardridge. | ||||||
Okairos is a Basel-Stadt-based company founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese and Stefano Colloca. | ||||||
Small molecule MKK4 inhibitors to treat acute and chronic liver diseases | ||||||
Topas Therapeutics is a nanoparticles loaded with Antigenic Peptides. | ||||||
Tacalyx is an antibodies for cancer founded in 2019. | ||||||
Actym Therapeutics is a microbial-based immunotherapy platform. | ||||||
Libra Therapeutics is a small Molecules for Neurodegenerative Indications founded in 2019. | ||||||
Machine learning-based platform for the discovery of new classes of anti-infectives | ||||||
Ruipeng Pet Healthcare is a Shenzhen-based company founded in 2013 by Yonghe Peng. | ||||||
Glox Therapeutics is an antibiotic therapeutics platform founded in 2023. | ||||||
